You have no items in your shopping cart.
Human Full-Length Membrane Proteins
Synthetic Nanodisc Platform
60% of Known Drug Targets Are Membrane Proteins
Aberrant membrane protein function is a central driver of numerous diseases, establishing them as "golden targets" in drug development. Currently, over 60% of drug targets are transmembrane proteins, and among antibody-based therapeutics, this figure exceeds 90%. Obtaining full-length membrane proteins with a "native conformation" and "functional activity" represents a critical bottleneck.
Leveraging its innovative Synthetic Nanodisc technology platform, Biorbyt delivers highly purified, soluble, full-length membrane proteins that retain native activity.
Synthetic Nanodisc
Synthetic Nanodiscs employ synthetic polymers to solubilize the cell membrane while utilizing native cellular phospholipids to form a nanodisc structure. The polymer integrates the membrane protein into the nanodisc, preserving its native spatial conformation and activity.
Advantages and Applications
Preparation Method | Advantages | Applications |
|---|---|---|
Synthetic Nanodisc | • Highly purified membrane proteins • High solubility & stability • Maintains biological activity • Detergent-Free • Mammalian expression system | • ELISA & SPR affinity analysis • Phage display screening • Immunization • Cell-based assays • Structural analysis |
Product Validation Data
Human CLDN6 full-length protein-synthetic nanodisc


Human CCR8 full-length protein-synthetic nanodisc



Membrane Protein Scaffold Systems
In the development of multi-spanning membrane drug targets, full-length membrane proteins with native conformation represent the optimal antigens. Achieving this goal requires the selection of an appropriate membrane protein scaffold system. Currently, nanodisc technology based on different scaffold materials is primarily classified into the following three categories:
Type | Scaffold Composition | Key Features | Typical Applications |
|---|---|---|---|
MSP Nanodisc | Membrane scaffold protein (derived from ApoA1) | Most established; uniform size (7–17 nm); genetically engineerable | Cryo-EM, NMR structural determination |
Synthetic Nanodisc | SMA / DIBMA copolymers | Directly "punched out" from cell membranes; preserves native lipids | Rapid membrane protein purification; functional studies |
PeptiNanodisc | Short amphipathic peptides | No pre-mixing of lipids required; "universal" scaffold; simple operation | High-throughput screening; membrane protein purification |
Biorbyt offers custom services for full-length human membrane proteins as well as other recombinant proteins, ensuring a consistent and reliable supply for drug development projects.